Aarti Drugs Ltd. (AARTIDRUGS)

Overview

Aarti Drugs Limited, established in 1984, is a comprehensive pharmaceutical company with global operations, focusing on the manufacture and marketing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations. With a strong presence in various therapeutic areas, the company caters to a wide spectrum of healthcare needs. It operates both in India and internationally, demonstrating a robust portfolio that spans across various medical disciplines, such as anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, and more. Aarti Drugs Limited is dedicated to improving healthcare through its diverse product range and contract manufacturing services, headquartered in Mumbai, India.

Products and Services

• APIs: Aarti Drugs provides an extensive range of Active Pharmaceutical Ingredients catering to various therapeutic areas like anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antibiotics, antidiabetics, Alzheimer's treatment, sedatives, vitamins, and alcoholism treatment among others. These APIs are crucial for the development and manufacture of effective medicinal products.
• Pharmaceutical Intermediates: This includes a range of intermediate products such as tinidazole, celecoxib, ciprofloxacin, clopidogrel, and more. These intermediates are essential components in the synthesis of complex APIs and formulations, showcasing Aarti Drugs’ capability in supporting diverse pharmaceutical manufacturing needs.
• Specialty Chemicals: The company offers a variety of specialty chemical products like benzene sulphonyl chloride, sodium benzene sulfinate, and calcium fluoride, among others. These products find application across different sectors, including pharmaceuticals, demonstrating the company’s versatility in chemical manufacturing.
• Development Products: Aarti Drugs is also engaged in the development of new products such as Itraconazole and Fluconazole for antifungal applications; Dabigatran as an anticoagulant; Ticagrelor for cardiovascular diseases; Sitagliptin for antidiabetics; and Alpha Lipoic Acid for antioxidants. This reflects the company's commitment to expanding its portfolio and contributing to advancements in healthcare.
• Contract Manufacturing Services: In addition to its core offerings, Aarti Drugs provides contract manufacturing services, enabling other pharmaceutical companies to leverage its manufacturing capabilities for their products. This service extends Aarti Drugs' reach beyond its own product line, positioning it as a key player in the pharmaceutical manufacturing industry.
• Dermatology Products: The company develops products to treat various dermatological conditions, including dermatitis, psoriasis, acne, and eczema. This diversification into dermatology underscores Aarti Drugs’ commitment to addressing a wide spectrum of medical conditions, enhancing overall healthcare outcomes.